Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12–17-year olds in Victoria, Australia

IMPORTANCE: COVID-19 mRNA vaccine-associated myocarditis has previously been described; however specific features in the adolescent population are currently not well understood. OBJECTIVE: To describe myocarditis adverse events following immunisation reported following any COVID-19 mRNA vaccines in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Daryl R, Clothier, Hazel J, Morgan, Hannah J, Roney, Emma, Shenton, Priya, Cox, Nicholas, Jones, Bryn O, Schrader, Silja, Crawford, Nigel W, Buttery, Jim P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunisation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240449/
https://www.ncbi.nlm.nih.gov/pubmed/36053607
http://dx.doi.org/10.1136/bmjpo-2022-001472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240449/
https://www.ncbi.nlm.nih.gov/pubmed/36053607
http://dx.doi.org/10.1136/bmjpo-2022-001472

Ejemplares similares